CVI Holdings’s Insmed INSM Stock Holding History

CVI Holdings’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,627	Closed	-$374K	–	50
2019 Q2	$374K	Buy	+14,627	New	+$407K	0.43%	27

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CVI Holdings's INSM Position: Q3 2019 in Review

CVI Holdings sold out of Insmed (INSM) in Q3 2019, closing a stake of 14,627 shares — an estimated $374K sold.

CVI Holdings first reported a position in INSM in Q2 2019 and held it in 1 quarter. The position peaked at $374K in Q2 2019. 157 funds tracked by Wall St. Rank hold INSM as of Q3 2019.

CVI Holdings reported no remaining Insmed position as of Q3 2019 after selling out during the quarter.
CVI Holdings sold 14,627 Insmed shares in Q3 2019, an estimated $374K.
CVI Holdings first reported a position in Insmed in Q2 2019 and held it in 1 quarter.
CVI Holdings's Insmed position peaked at $374K in Q2 2019.
157 funds tracked by Wall St. Rank held Insmed as of Q3 2019.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.